← Back to news
NewsHEREDITARY CANCER IN CLINICAL PRACTICESunday, March 22, 2026 · March 22, 2026

A retrospective analysis of risk-reducing salpingo-oophorectomy performed in women diagnosed with hereditary breast and ovarian cancer at our institution.

WHY IT MATTERS

Recent peer-reviewed research on Primary peritoneal carcinoma that may be relevant for patients and caregivers.

Hereditary breast and ovarian cancer (HBOC) confers a markedly increased lifetime risk of breast and ovarian cancers. As no effective surveillance method for early detection of ovarian cancer has been established, risk-reducing salpingo-oophorectomy (RRSO) is recommended for patients with HBOC to pr...

Read on PubMed
Read the original at Hereditary cancer in clinical practice
ResearchPubMedPrimary peritoneal carcinoma

Related conditions

Primary peritoneal carcinoma

Related news

Int J Circumpolar Health · -251 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -221 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -221 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
Mol Ther Nucleic Acids · -53 days ago
The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena
Published in Mol Ther Nucleic Acids. Giangrande PH et al.